Ð¡Ð¾Ð²ÐµÑ Ð¼Ð¸Ð½Ð¸ÑÑÑов ТÑÑÑии в одноÑÑоÑоннем поÑÑдке пÑинÑл пÑÐ¸Ð³Ð¾Ð²Ð¾Ñ Ð¾ пÑодлении безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ð² ÑÑÑане Ð´Ð»Ñ ÑоÑÑиÑн Ñ 30 дней до 60 дней.
РеÑение вÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и бÑÐ´ÐµÑ Ð´ÐµÐ¹ÑÑвиÑелÑно до 31 декабÑÑ 2012 года.
СÑммаÑное пÑебÑвание гÑаждан РоÑÑии Ð´Ð»Ñ ÑеÑÑиÑоÑии ТÑÑÑии не надо пÑевÑÑаÑÑ 90 дней в ÑеÑение каждого 180-дневного пеÑиода.
Ðапомним, коÑоÑÑй оÑмена визового Ñежима Ð¼ÐµÐ¶Ð´Ñ Ð¢ÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. ÐоÑле оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли бÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 дней.
Ð' иÑле 2011 года ТÑÑ ÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ñади ÑоÑÑиÑн пÑежде 60 дней, ÑÑо вÑеменное положение иÑÑекло 31 декабÑÑ 2011 года и пеÑед ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ пÑиÑÑÑÑÑвие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, кÑо Ñ
оÑÐµÑ Ð±ÑÑÑ Ð² ТÑÑÑии Ãóëüíàð òóð â Àñòàíå - ãîðÿùèå òóðû более 60 дней, надо ÑанÑÑе обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии за визой.
Ð"Ð°Ð±Ñ Ð¿Ð¾Ð¿Ð°ÑÑÑ Ð´Ð»Ñ Ð±Ð¾Ð»ÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑкиÑ
Ð¸Ð³Ñ Ð² Ðондоне, не непÑеменно вÑплаÑиваÑÑ Ð¾Ð³ÑомнÑе аÑжанÑ, Ñак Ñовно нагÑÑзиÑÑÑÑ Ð¼Ð½Ð¾Ð³Ð¾ ÑпоÑобов ÑÑкономиÑÑ .
Ð'еÑплаÑÐ½Ð°Ñ Ð¿Ð¾ÑÑдок поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов ÑвидеÑÑ ÐÑелиÑе и около ÑÑом не поÑÑаÑиÑÑ Ð½Ð° Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
Ради некоÑоÑÑÑ
диÑÑиплин пÑиобÑеÑаÑÑ Ð±Ð¸Ð»ÐµÑ Ð¸ Ð²ÐºÐ¾Ð½ÐµÑ Ð½Ðµ поÑÑебÑеÑÑÑ. Так, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑоÑезаÑÑÑÑ ÑообÑазно ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð²ÑеÑаки, ÑÑо нÑждаÑÑÑÑ ÑделаÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑо пÑиÑ
одиÑÑ Ð² нÑжное пеÑиод в нÑжное меÑÑо. Ðомимо ÑÑого в Ð"айд-паÑке и Ð'икÑоÑиÑ-паÑке бÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, ÑообÑазно кР¾ÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
СамÑй деÑевÑй ãîðÿ÷èå òóðû â Äóáàé. Îòäûõàéòå ñ íàìè! ÑÑ
ваÑка ÑвидеÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" взÑÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. ÐÑполнÑÑÑ ÑÑо дозволиÑелÑно в ÑпеÑиалÑнÑÑ
авÑомаÑизиÑованнÑÑ
пÑнкÑаÑ
пÑокаÑа Barclays Circle Hire. Ðзза пеÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом плаÑа не взимаеÑÑÑ, а лÑÑÑий ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ Ð²Ñего ?1.
Словно извеÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ
ÑÑÐ°Ñ Ð¼Ð¾Ð¶Ð½Ð¾, ÑÑав ÑÑаÑÑником пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfing: ÑÐ»ÐµÐ½Ñ ÑÑой козни безвозмездно пÑедоÑÑавлÑÑÑ Ð´Ð¾Ð±ÑожелаÑÐµÐ»Ñ Ð´ÑÑÐ³Ñ Ð½Ð¾Ñлег во вÑÐµÐ¼Ñ Ð¿ÑÑеÑеÑÑвий. Разве оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" за неболÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ можно доволÑно ÑазбиÑÑ Ð² ÑаÑÑном ÑадÑ.
ÐекоÑоÑÑй лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ð·Ð° вÑ
од. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ ÑообÑазно вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, пÑеимÑÑеÑÑвенно Ñ
оÑоÑо гÑлÑÑÑ ÑообÑазно его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'езвозмездно дозволено понимаÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Ð¢ÐµÐ¹Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной поÑÑÑеÑной галеÑеи. ÐпÑÑÑ Ð¾Ð´Ð½Ð¾ кÑлÑÑÑÑное меÑа, на коÑо Ñое не нÑжно пÑиобÑеÑаÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" пеÑемена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑой пÑиÑ
одиÑе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе оÑделÑнÑй ÑÑÑки ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" Ð¾Ñ Ð´Ð¶Ð°Ð·Ð° наканÑне Ñолка, около ÑÑом Ñади вÑ
од не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное вÑÐµÐ¼Ñ Ð¿Ð¾ пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð¼Ð¾Ð¶Ð½Ð¾ поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ
â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ Ð¿Ð¾ понеделÑникам, вÑоÑникам и ÑÑедам и опÑÑÑ Ð¶Ðµ оÑкÑÑÑÑ Ð´Ð»Ñ Ð²ÑеÑ
желаÑÑиÑ
.
Care your self
понедельник, 19 мая 2014 г.
четверг, 24 октября 2013 г.
Commenting on the prospectus control published today Sir Andrew Dillon, Chief Manager of DELIGHTFULLY
KIND, the healthcare handling thickness, has today published incontrovertible cheque guidance not recommending cabazitaxel (Jevtana, Sanofi) in colloid with prednisone or prednisolone as a subordinate contour treatment with a view prostate cancer.
Commenting on the draft advisement published today Sir Andrew Dillon, Chief Manager of DELIGHTFULLY said: We need to be certain that unexplored treatments afford enough benefits to patients to excuse the informative resources the NHS would constraint to make good available. Although cabazitaxel has been shown to be compelling in extending duration, it is also associated with a reckon of side effects [7]. The body was responsible there the universe of the health-related eminence of life story tidings provided by the manufacturer.
Once these factors had been enchanted into account, the independent Body appraising this dose concluded that it would not afford enough health emoluments to substantiate its charge, which means it would not be a get compelling turn to account of narrow NHS resources.
The drawing guidance on cabazitaxel is any longer with consultees, who have the opportunity to allure against it. Until POLITE issues terminal handling, NHS bodies should exhort decisions locally on the funding of definitive treatments. This draft guidance does not middling that people currently irresistible cabazitaxel will leave off receiving it. They have the opportunity to persevere in treatment until they and their clinicians consideration it appropriate to stop.
Kevin Stephensâ media hype to FD Áîðîâîå áàçû îòäûõà â Êàçàõñòàíå is thicken to again lift the Coterieâs economic engagement and schedule to save ecumenical expansion
The Almac Timber is pleased to publish the meeting of Kevin Stephens to the administrator attitude of Finance Conductor, Almac Assemblage, with effect from 1 January 2012.
Kevin desire get o nus in place of all financial aspects of Almac Alliance activities globally, unequalled the monetary directing teams with a view all wide-ranging operations, supporting the planned expansion of the affair and co-ordinating economic rule and reporting during the Group.
After graduating from Queenâs University, Belfast, with a degree in Economics, Kevin accomplished as a Chartered Accountant with Ernst Under age and then worked since 14 years with Kemira NI as Financial Controller.
Inhibitex is a clinical-stage biopharmaceutical associates dedicated to the maturing of innovative products that can treat or baffle acute infections, whose teach concentrate is on the development of nucleotide/nucleoside analogs in compensation the treatment of hepatitis C virus (HCV). Its guide HCV asset is INX-189, an enunciated nucleotide polymerase (NS5B) inhibitor in Shape II maturity that has exhibited vigorous antiviral work, a acute obstacle to resistance and pan-genotypic cove rage. Nucleotides/nucleosides are emerging as an weighty classification of antivirals that may do a serious capacity as the sturdiness of prospective direct-acting antiviral-only composition approaches to HCV treatment.
The purchase of Inhibitex builds on Bristol-Myers Squibb's hunger history of discovering, developing and delivering innovative uncharted medicines in virology and enriches our portfolio of investigational medicines in the interest hepatitis C, said Lamberto Andreotti, chief administrator director, Bristol-Myers Squibb. There is eloquent unmet medical basic in hepatitis C. This property represents an important investment in the long-term growth of the company.
This minutes puts INX-189 and the House's other contagious affliction assets in the hands of an system that can more optimally come to light them and which believes as strongly as we do in INX-189's potential in the treatment of chronic HCV, said Russell Plumb, President and Chief Foreman O fficer of Inhibitex. Bristol-Myers Squibb's expertise in antiviral dope increase, and its existing complementary portfolio, will assure that the dormant of INX-189 is realized as enter in of unborn word-of-mouth league therapies because of millions of patients in trouble around the world.
Bristol-Myers Squibb continues to demand Áîðîâîå îòäûõ - öåíû advances in the react to of hepatitis C analysis and development by internal growth and selective partnerships, said Elliott Sigal, M.D., Ph.D., foreman imperfection president, chief well-regulated public servant and president, RD, Bristol-Myers Squibb. The addendum of Inhibitex's nucleotide polymerase inhibitor to our own rosy portfolio, which includes other direct-acting antivirals, brings additional options to mature all-oral regimens with cured drug rates, shorter duration of cure and slash toxicity than the known regulative of care.
The records is expected to be diluti ve to earnings looking for Bristol-Myers Squibb through 2016, with an expected impact on earnings per portion of close to $0.04 in 2012 and give $0.05 in 2013.
Underneath the terms of the thorough compact, Bristol-Myers Squibb will-power commence a exchange skiff offer to obtain all of the conspicuous shares of Inhibitexâs conventional selection for $26.00 per share. The closing of the jolly-boat sell is cause to undergo to customary terms and conditions, including the row-boat of a number of shares that constitutes at least a bulk of Inhibitexâs first-rate shares of standard lineage (on a fully diluted principle) and running out or suffix of the waiting time high the Hart-Scott-Rodino Antitrust Improvements Act. The accord also provides for the parties to obtain, excuse to everyday conditions, a merging to be completed following the culmination of the skiff put forward which would end result in all shares not tendered in the rowing-boat offer being converted into the dexter to obtain $26.00 per allowance in cash. The mingling agreement contains a catering underneath which Inhibitex has agreed not to approach any competing offers for the company. Bristol-Myers Squibb bequeath finance the purchase from its existing mazuma change resources. The companies upon the wagon offer to close almost thirty days after commencement of the dinghy offer.
Citi is serving as economic advisor to Bristol-Myers Squibb in connection with the acquisition and Kirkland Ellis LLP is its proper advisor. Acclaim Suisse Securities (USA) LLC is serving as monetary advisor to Inhibitex in uniting with the possessions and Dechert LLP is its legitimate advisor.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a extensive biopharmaceutical troop whose commission is to devise, enlarge on and bring into the world innovative medicines that help patients gain beyond consequential diseases.
Commenting on the draft advisement published today Sir Andrew Dillon, Chief Manager of DELIGHTFULLY said: We need to be certain that unexplored treatments afford enough benefits to patients to excuse the informative resources the NHS would constraint to make good available. Although cabazitaxel has been shown to be compelling in extending duration, it is also associated with a reckon of side effects [7]. The body was responsible there the universe of the health-related eminence of life story tidings provided by the manufacturer.
Once these factors had been enchanted into account, the independent Body appraising this dose concluded that it would not afford enough health emoluments to substantiate its charge, which means it would not be a get compelling turn to account of narrow NHS resources.
The drawing guidance on cabazitaxel is any longer with consultees, who have the opportunity to allure against it. Until POLITE issues terminal handling, NHS bodies should exhort decisions locally on the funding of definitive treatments. This draft guidance does not middling that people currently irresistible cabazitaxel will leave off receiving it. They have the opportunity to persevere in treatment until they and their clinicians consideration it appropriate to stop.
Kevin Stephensâ media hype to FD Áîðîâîå áàçû îòäûõà â Êàçàõñòàíå is thicken to again lift the Coterieâs economic engagement and schedule to save ecumenical expansion
The Almac Timber is pleased to publish the meeting of Kevin Stephens to the administrator attitude of Finance Conductor, Almac Assemblage, with effect from 1 January 2012.
Kevin desire get o nus in place of all financial aspects of Almac Alliance activities globally, unequalled the monetary directing teams with a view all wide-ranging operations, supporting the planned expansion of the affair and co-ordinating economic rule and reporting during the Group.
After graduating from Queenâs University, Belfast, with a degree in Economics, Kevin accomplished as a Chartered Accountant with Ernst Under age and then worked since 14 years with Kemira NI as Financial Controller.
Inhibitex is a clinical-stage biopharmaceutical associates dedicated to the maturing of innovative products that can treat or baffle acute infections, whose teach concentrate is on the development of nucleotide/nucleoside analogs in compensation the treatment of hepatitis C virus (HCV). Its guide HCV asset is INX-189, an enunciated nucleotide polymerase (NS5B) inhibitor in Shape II maturity that has exhibited vigorous antiviral work, a acute obstacle to resistance and pan-genotypic cove rage. Nucleotides/nucleosides are emerging as an weighty classification of antivirals that may do a serious capacity as the sturdiness of prospective direct-acting antiviral-only composition approaches to HCV treatment.
The purchase of Inhibitex builds on Bristol-Myers Squibb's hunger history of discovering, developing and delivering innovative uncharted medicines in virology and enriches our portfolio of investigational medicines in the interest hepatitis C, said Lamberto Andreotti, chief administrator director, Bristol-Myers Squibb. There is eloquent unmet medical basic in hepatitis C. This property represents an important investment in the long-term growth of the company.
This minutes puts INX-189 and the House's other contagious affliction assets in the hands of an system that can more optimally come to light them and which believes as strongly as we do in INX-189's potential in the treatment of chronic HCV, said Russell Plumb, President and Chief Foreman O fficer of Inhibitex. Bristol-Myers Squibb's expertise in antiviral dope increase, and its existing complementary portfolio, will assure that the dormant of INX-189 is realized as enter in of unborn word-of-mouth league therapies because of millions of patients in trouble around the world.
Bristol-Myers Squibb continues to demand Áîðîâîå îòäûõ - öåíû advances in the react to of hepatitis C analysis and development by internal growth and selective partnerships, said Elliott Sigal, M.D., Ph.D., foreman imperfection president, chief well-regulated public servant and president, RD, Bristol-Myers Squibb. The addendum of Inhibitex's nucleotide polymerase inhibitor to our own rosy portfolio, which includes other direct-acting antivirals, brings additional options to mature all-oral regimens with cured drug rates, shorter duration of cure and slash toxicity than the known regulative of care.
The records is expected to be diluti ve to earnings looking for Bristol-Myers Squibb through 2016, with an expected impact on earnings per portion of close to $0.04 in 2012 and give $0.05 in 2013.
Underneath the terms of the thorough compact, Bristol-Myers Squibb will-power commence a exchange skiff offer to obtain all of the conspicuous shares of Inhibitexâs conventional selection for $26.00 per share. The closing of the jolly-boat sell is cause to undergo to customary terms and conditions, including the row-boat of a number of shares that constitutes at least a bulk of Inhibitexâs first-rate shares of standard lineage (on a fully diluted principle) and running out or suffix of the waiting time high the Hart-Scott-Rodino Antitrust Improvements Act. The accord also provides for the parties to obtain, excuse to everyday conditions, a merging to be completed following the culmination of the skiff put forward which would end result in all shares not tendered in the rowing-boat offer being converted into the dexter to obtain $26.00 per allowance in cash. The mingling agreement contains a catering underneath which Inhibitex has agreed not to approach any competing offers for the company. Bristol-Myers Squibb bequeath finance the purchase from its existing mazuma change resources. The companies upon the wagon offer to close almost thirty days after commencement of the dinghy offer.
Citi is serving as economic advisor to Bristol-Myers Squibb in connection with the acquisition and Kirkland Ellis LLP is its proper advisor. Acclaim Suisse Securities (USA) LLC is serving as monetary advisor to Inhibitex in uniting with the possessions and Dechert LLP is its legitimate advisor.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a extensive biopharmaceutical troop whose commission is to devise, enlarge on and bring into the world innovative medicines that help patients gain beyond consequential diseases.
воскресенье, 5 мая 2013 г.
ÐиÑнейленд â ÑÑо оÑобÑй, неповÑоÑимÑй миÑ, валÑÑжнÑй
ÐÑлÑÑÑилÑÐ¼Ñ Ð£Ð¾Ð»Ñа Ð"иÑÐ½ÐµÑ Ð´Ð°Ð²Ð½Ð¾ ÑÑали неоÑÑемлемой ÑаÑÑÑÑ Ð¿Ð¾Ð¿ÑлÑÑной кÑлÑÑÑÑÑ. ÐекоÑоÑÑе из ниÑ
пÑÐ¸Ð·Ð½Ð°Ð½Ñ Ð¼Ð¸ÑовÑми ÑедевÑами в облаÑÑи мÑлÑÑипликаÑии. ÐиÑ, ÑÐ¾Ð·Ð´Ð°Ð½Ð½Ð°Ñ ÑаланÑливÑм Ñ
Ñдожником, наÑÑолÑко велика, ÑколÑко еÑ' Ñ
ваÑило Ð´Ð»Ñ Ð¿Ñоизведение гÑандиознÑÑ
ÑемаÑиÑеÑкиÑ
паÑков ÑазвлеÑений â" Ð"иÑнейлендов â" в СШРи Японии.
Ðа волне Ð¸Ñ Áîðîâîå â Êàçàõñòàíå - öåíû. Ïîäðîáíîñòè íà ñàéòå! ÑÑÐ¿ÐµÑ Ð° бÑло пÑинÑÑо пÑÐ¸Ð³Ð¾Ð²Ð¾Ñ Ð¾ÑноваÑÑ Ð½Ð¾Ð²Ñй Ð"иÑнейленд в ÐвÑопе. Ðа занÑÑие «пÑинимаÑÑей ÑÑоÑонÑ» пÑобовалиÑÑ ÐÑÐ¿Ð°Ð½Ð¸Ñ Ð¸ ФÑанÑиÑ. ÐеÑевеÑила, в ÑÐ¸Ð»Ñ ÐºÐ»Ð¸ маÑа и ÑинанÑовÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей, поÑледнÑÑ. Ð"иÑнейленд, оÑкÑÑвÑийÑÑ Ð² апÑеле 1992 возÑаÑÑ, ÑаÑположилÑÑ Ð² гоÑодке ÐаÑн-лÑ-Ð'але, недалеко Ð¾Ñ ÐаÑижа. Ð'олÑебÑÑво мÑлÑÑипликаÑии Ð"иÑÐ½ÐµÑ Ð¸ ÑиÑоÑайÑий ÑпекÑÑ ÑазвлеÑений пÑевÑаÑили Ð"иÑнейленд в пÑизнаннÑй ÑÑÑиÑÑиÑеÑкий оазиÑ. ÐÐ¸Ð»Ð»Ð¸Ð¾Ð½Ñ Ð»Ñдей кÑÑг год ÑÑезжаÑÑÑÑ Ð²Ð¾ ФÑанÑиÑ, Ð´Ð»Ñ Ð¿Ð¾ÑеÑиÑÑ Ð¾Ð¶Ð¸Ð²ÑÑÑ ÑказкÑ.
ФÑанÑÑзÑкий Ð"иÑнейленд ÑаÑкинÑлÑÑ Ð½Ð° плоÑади без малого 20 квадÑаÑнÑÑ ÐºÐ¸Ð»Ð¾Ð¼ÐµÑÑов и вклÑÑÐ°ÐµÑ Ð² ÑебÑ, помимо двÑÑ Ð¿Ð°Ñков ÑазвлеÑений, 11 оÑелей, кÑпеÑеÑкий оÑаг, ÑенниÑнÑе коÑÑÑ, Ð¿Ð¾Ð»Ñ Ñади голÑÑа и неÑмеÑное ÑиÑÑа ÑÑвениÑнÑÑ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ñиков и ÑеÑÑоÑанов. ÐдеÑÑ ÐºÐ°Ð¶Ð´Ñй найдÑ'Ñ ÑÑо-нибÑÐ´Ñ ÑообÑазно дÑÑе: бÑÐ´Ñ Ñо ÑамоÑÑоÑÑелÑнÑй ÑеÑÑоÑан Рейн-ФоÑеÑÑ, ÑÑилизованнÑй пеÑед джÑнгли Ðмазонки, Ñазве ÐºÐ¸Ð½Ð¾ÐºÐ¾Ð¼Ð¿Ð»ÐµÐºÑ Â«Ð"омон СинеплекÑ», извеÑÑнÑй Ñвоими ÑамÑми ÑиÑокими во ФÑанÑии ÑкÑанами. ÐÑбиÑели Ñопинга Ñакже не оÑÑанÑÑÑÑ ÑавнодÑÑнÑми â" ÑенÑÑ Ð"иÑней Ð'илладж пÑÐµÐ´Ð»Ð¾Ð¶Ð¸Ñ Ð¸Ð¼ маÑÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей пополниÑÑ Ð¿ÑинадлежаÑий гаÑдеÑоб.
ÐаÑÑÑенной ÑвлÑеÑÑÑ Ð¸ мÑзÑкалÑÐ½Ð°Ñ Ð¿ÑогÑамма. ÐонÑеÑÑÑ Ð¸ диÑкоÑеки не дадÑÑ ÑоÑкÑÑиÑÑÑÑ Ð½Ð¸ÐºÐ¾Ð¼Ñ â" Ð²ÐµÐ´Ñ Ð·Ð´ÐµÑÑ Ð¿ÑедÑÑ Ð°Ð²Ð»ÐµÐ½ ÑелÑнÑй ÑпекÑÑ Ð¶Ð°Ð½Ñов â" ÑеÑез ÑеÑÑо пÑедваÑиÑелÑно джаза. Ð'ÑклÑÑÐ°Ñ Ñого, в Ð"иÑнейленде можно пÑовеÑÑи и лиÑнÑе меÑопÑиÑÑиÑ, Ñакие как ÑиÑло ÑÐ¾Ð¶Ð´ÐµÐ½Ð¸Ñ alias ÑвадÑба. ÐбÑÑановка неÑконÑаемого пÑаздника оÑÑÐ°Ð²Ð¸Ñ ÑамÑе ÑÑкие и ÑадоÑÑнÑе впеÑаÑлениÑ.
Ð"иÑнейленд ãîðÿùèå òóðû èç Êàçàõñòàíà. Îòäûõàéòå ñ íàìè! â" ÑÑо оÑобÑй, неповÑоÑимÑй обÑеÑÑво, набиÑÑй ÑадоÑÑнÑÑ ÑмоÑий и ÑÑÐºÐ¸Ñ ÐºÑаÑок, ÑождÑ'ннÑй ÑанÑазией добÑого ÑказоÑника. ÐоÑÑомÑ, оÑпÑавлÑÑÑÑ Ð² пÑÑÑ Ð² ÐаÑиж, не забÑдÑÑе заглÑнÑÑÑ Ð² ÑÑÑ ÑÐºÐ°Ð·ÐºÑ Ð´Ð»Ñ Ð´ÐµÑей и взÑоÑлÑÑ . Ð"иÑнейленд во ФÑа нÑии доволÑно идеалÑнÑм меÑÑом оÑдÑÑ Ð° ÑÑÐ¾Ð±Ñ Ð²Ñей ÑемÑи â" деÑи еÑÑ' долго бÑдÑÑ Ð¾Ð³Ð»Ð°ÑаÑÑ Ð¾ÑноÑиÑелÑнÑй Ñвиденном, а взÑоÑлÑе окÑнÑÑÑÑÑ Ð² ÑказоÑнÑй Ð¼Ð¸Ñ Ð¸ вÑпомнÑÑ, ÑÑо когда-Ñо Ñами бÑли деÑÑми.
ÐÑÑг акÑеÑÑÑаÑов Ermenegildo Zegna, Ð'еÑна- ÐеÑо 2012, Ñоздана ÑÑÐ¾Ð±Ñ Ð¼ÑжÑкого обÑаза и нÑнÑе пÑедÑÑавлена в наÑÐ¸Ñ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ð°Ñ Ð² ÐÐ°Ð½Ð½Ð°Ñ Ð¸ ÐаÑиже.
ÐлеганÑÐ½Ð°Ñ ÐºÐ¾Ð¶Ð°Ð½Ð°Ñ Ð¾Ð±ÑÐ²Ñ ÑÑÑной ÑабоÑÑ, ÑÑÑогие поÑÑÑели из кÑокодиловой кожи, ÑÑкие ÑолнеÑнÑе оÑки и ÑаÑÑÑ, вÑполненнÑе из ÑонÑайÑего жаккаÑдового Ñелка â" Ð½ÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ñе ÑоÑÑавлÑÑÑие Ñади ÑÑкого леÑнего гаÑÐ´ÐµÑ Ð¾Ð±Ð°.
Ð' каÑеÑÑве компенÑаÑии за длиннÑй вÑÐ³Ð¾Ð²Ð¾Ñ Ð´Ð»Ñ Ð¸Ð·ÑÑканном Ñелке вÑÑоÑайÑего каÑеÑÑва, в ÑÐ°Ð¼ÐºÐ°Ñ Ð»ÐµÑней коллекÑии одеждÑ, акÑеÑÑÑаÑÑ Ð¿Ð¾Ð»ÑÑилиÑÑ ÑÑÑогими, мÑжеÑÑвеннÑм, ÑоÑкоÑнÑми и конÑÑаÑÑнÑми. ÐоÑеÑÑ Ð²ÑÑоÑайÑего клаÑÑа, вÑполненнÑе вÑÑÑнÑÑ, ÑÑадиÑионно Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÐºÐ¸ÑÑоÑками из блеÑÑÑÑей кожи. ТÑÑли деÑби из оÑполиÑованной вÑÑÑнÑÑ Ð³Ð»Ð°Ð´ÐºÐ¾Ð¹ кожи Ñ Ð¿ÑоÑиÑÑм ноÑом, идеалÑно ÑоÑеÑаÑÑÑÑ Ñ Ð¼Ð¾Ð´Ð½Ñм ÑлеменÑом в виде кÑепкой подоÑÐ²Ñ Ð¸Ð· беÑÑвеÑной ÑезинÑ. СаквоÑжи из кожи аллигаÑоÑа иÑÐ¿Ð¾Ð»Ð½ÐµÐ½Ñ Ð² ÑоÑнÑÑ ÑеÑÐºÐ¸Ñ Ð»Ð¸Ð½Ð¸ÑÑ Ð¸ Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÑÐ»ÐµÐ³Ð°Ð½Ñ Ð½Ñми меÑаллиÑеÑкими ÑлеменÑами. Ð"войнÑе поÑÑÑели и клаÑÑиÑеÑкие бÑмажники из кожи аллигаÑоÑа в ÑоÑеÑании Ñ Ð¿Ð¾Ð»Ð¸ÑованнÑми меÑаллиÑеÑкими замками â" неоÑÑÐµÐ¼Ð»ÐµÐ¼Ð°Ñ Ð¾Ð±Ð»Ð¾Ð¼Ð¾Ðº безÑпÑеÑного обÑаза, обÑединивÑего Ð¼ÐµÐ¶Ð´Ñ Ð¸ оÑиÑиоз.
ÐкÑклÑзивнÑе леÑние акÑеÑÑÑаÑÑ Zegna идеалÑно дополнÑÑ Ð²Ð°Ñ Ð³Ð°ÑдеÑоб Ñазве полноÑÑÑÑ Ð¿ÑеобÑазÑÑ ÐµÐ³Ð¾, поднÑв на дÑÑгой ÑÑовенÑ.
Ðа волне Ð¸Ñ Áîðîâîå â Êàçàõñòàíå - öåíû. Ïîäðîáíîñòè íà ñàéòå! ÑÑÐ¿ÐµÑ Ð° бÑло пÑинÑÑо пÑÐ¸Ð³Ð¾Ð²Ð¾Ñ Ð¾ÑноваÑÑ Ð½Ð¾Ð²Ñй Ð"иÑнейленд в ÐвÑопе. Ðа занÑÑие «пÑинимаÑÑей ÑÑоÑонÑ» пÑобовалиÑÑ ÐÑÐ¿Ð°Ð½Ð¸Ñ Ð¸ ФÑанÑиÑ. ÐеÑевеÑила, в ÑÐ¸Ð»Ñ ÐºÐ»Ð¸ маÑа и ÑинанÑовÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей, поÑледнÑÑ. Ð"иÑнейленд, оÑкÑÑвÑийÑÑ Ð² апÑеле 1992 возÑаÑÑ, ÑаÑположилÑÑ Ð² гоÑодке ÐаÑн-лÑ-Ð'але, недалеко Ð¾Ñ ÐаÑижа. Ð'олÑебÑÑво мÑлÑÑипликаÑии Ð"иÑÐ½ÐµÑ Ð¸ ÑиÑоÑайÑий ÑпекÑÑ ÑазвлеÑений пÑевÑаÑили Ð"иÑнейленд в пÑизнаннÑй ÑÑÑиÑÑиÑеÑкий оазиÑ. ÐÐ¸Ð»Ð»Ð¸Ð¾Ð½Ñ Ð»Ñдей кÑÑг год ÑÑезжаÑÑÑÑ Ð²Ð¾ ФÑанÑиÑ, Ð´Ð»Ñ Ð¿Ð¾ÑеÑиÑÑ Ð¾Ð¶Ð¸Ð²ÑÑÑ ÑказкÑ.
ФÑанÑÑзÑкий Ð"иÑнейленд ÑаÑкинÑлÑÑ Ð½Ð° плоÑади без малого 20 квадÑаÑнÑÑ ÐºÐ¸Ð»Ð¾Ð¼ÐµÑÑов и вклÑÑÐ°ÐµÑ Ð² ÑебÑ, помимо двÑÑ Ð¿Ð°Ñков ÑазвлеÑений, 11 оÑелей, кÑпеÑеÑкий оÑаг, ÑенниÑнÑе коÑÑÑ, Ð¿Ð¾Ð»Ñ Ñади голÑÑа и неÑмеÑное ÑиÑÑа ÑÑвениÑнÑÑ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ñиков и ÑеÑÑоÑанов. ÐдеÑÑ ÐºÐ°Ð¶Ð´Ñй найдÑ'Ñ ÑÑо-нибÑÐ´Ñ ÑообÑазно дÑÑе: бÑÐ´Ñ Ñо ÑамоÑÑоÑÑелÑнÑй ÑеÑÑоÑан Рейн-ФоÑеÑÑ, ÑÑилизованнÑй пеÑед джÑнгли Ðмазонки, Ñазве ÐºÐ¸Ð½Ð¾ÐºÐ¾Ð¼Ð¿Ð»ÐµÐºÑ Â«Ð"омон СинеплекÑ», извеÑÑнÑй Ñвоими ÑамÑми ÑиÑокими во ФÑанÑии ÑкÑанами. ÐÑбиÑели Ñопинга Ñакже не оÑÑанÑÑÑÑ ÑавнодÑÑнÑми â" ÑенÑÑ Ð"иÑней Ð'илладж пÑÐµÐ´Ð»Ð¾Ð¶Ð¸Ñ Ð¸Ð¼ маÑÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей пополниÑÑ Ð¿ÑинадлежаÑий гаÑдеÑоб.
ÐаÑÑÑенной ÑвлÑеÑÑÑ Ð¸ мÑзÑкалÑÐ½Ð°Ñ Ð¿ÑогÑамма. ÐонÑеÑÑÑ Ð¸ диÑкоÑеки не дадÑÑ ÑоÑкÑÑиÑÑÑÑ Ð½Ð¸ÐºÐ¾Ð¼Ñ â" Ð²ÐµÐ´Ñ Ð·Ð´ÐµÑÑ Ð¿ÑедÑÑ Ð°Ð²Ð»ÐµÐ½ ÑелÑнÑй ÑпекÑÑ Ð¶Ð°Ð½Ñов â" ÑеÑез ÑеÑÑо пÑедваÑиÑелÑно джаза. Ð'ÑклÑÑÐ°Ñ Ñого, в Ð"иÑнейленде можно пÑовеÑÑи и лиÑнÑе меÑопÑиÑÑиÑ, Ñакие как ÑиÑло ÑÐ¾Ð¶Ð´ÐµÐ½Ð¸Ñ alias ÑвадÑба. ÐбÑÑановка неÑконÑаемого пÑаздника оÑÑÐ°Ð²Ð¸Ñ ÑамÑе ÑÑкие и ÑадоÑÑнÑе впеÑаÑлениÑ.
Ð"иÑнейленд ãîðÿùèå òóðû èç Êàçàõñòàíà. Îòäûõàéòå ñ íàìè! â" ÑÑо оÑобÑй, неповÑоÑимÑй обÑеÑÑво, набиÑÑй ÑадоÑÑнÑÑ ÑмоÑий и ÑÑÐºÐ¸Ñ ÐºÑаÑок, ÑождÑ'ннÑй ÑанÑазией добÑого ÑказоÑника. ÐоÑÑомÑ, оÑпÑавлÑÑÑÑ Ð² пÑÑÑ Ð² ÐаÑиж, не забÑдÑÑе заглÑнÑÑÑ Ð² ÑÑÑ ÑÐºÐ°Ð·ÐºÑ Ð´Ð»Ñ Ð´ÐµÑей и взÑоÑлÑÑ . Ð"иÑнейленд во ФÑа нÑии доволÑно идеалÑнÑм меÑÑом оÑдÑÑ Ð° ÑÑÐ¾Ð±Ñ Ð²Ñей ÑемÑи â" деÑи еÑÑ' долго бÑдÑÑ Ð¾Ð³Ð»Ð°ÑаÑÑ Ð¾ÑноÑиÑелÑнÑй Ñвиденном, а взÑоÑлÑе окÑнÑÑÑÑÑ Ð² ÑказоÑнÑй Ð¼Ð¸Ñ Ð¸ вÑпомнÑÑ, ÑÑо когда-Ñо Ñами бÑли деÑÑми.
ÐÑÑг акÑеÑÑÑаÑов Ermenegildo Zegna, Ð'еÑна- ÐеÑо 2012, Ñоздана ÑÑÐ¾Ð±Ñ Ð¼ÑжÑкого обÑаза и нÑнÑе пÑедÑÑавлена в наÑÐ¸Ñ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ð°Ñ Ð² ÐÐ°Ð½Ð½Ð°Ñ Ð¸ ÐаÑиже.
ÐлеганÑÐ½Ð°Ñ ÐºÐ¾Ð¶Ð°Ð½Ð°Ñ Ð¾Ð±ÑÐ²Ñ ÑÑÑной ÑабоÑÑ, ÑÑÑогие поÑÑÑели из кÑокодиловой кожи, ÑÑкие ÑолнеÑнÑе оÑки и ÑаÑÑÑ, вÑполненнÑе из ÑонÑайÑего жаккаÑдового Ñелка â" Ð½ÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ñе ÑоÑÑавлÑÑÑие Ñади ÑÑкого леÑнего гаÑÐ´ÐµÑ Ð¾Ð±Ð°.
Ð' каÑеÑÑве компенÑаÑии за длиннÑй вÑÐ³Ð¾Ð²Ð¾Ñ Ð´Ð»Ñ Ð¸Ð·ÑÑканном Ñелке вÑÑоÑайÑего каÑеÑÑва, в ÑÐ°Ð¼ÐºÐ°Ñ Ð»ÐµÑней коллекÑии одеждÑ, акÑеÑÑÑаÑÑ Ð¿Ð¾Ð»ÑÑилиÑÑ ÑÑÑогими, мÑжеÑÑвеннÑм, ÑоÑкоÑнÑми и конÑÑаÑÑнÑми. ÐоÑеÑÑ Ð²ÑÑоÑайÑего клаÑÑа, вÑполненнÑе вÑÑÑнÑÑ, ÑÑадиÑионно Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÐºÐ¸ÑÑоÑками из блеÑÑÑÑей кожи. ТÑÑли деÑби из оÑполиÑованной вÑÑÑнÑÑ Ð³Ð»Ð°Ð´ÐºÐ¾Ð¹ кожи Ñ Ð¿ÑоÑиÑÑм ноÑом, идеалÑно ÑоÑеÑаÑÑÑÑ Ñ Ð¼Ð¾Ð´Ð½Ñм ÑлеменÑом в виде кÑепкой подоÑÐ²Ñ Ð¸Ð· беÑÑвеÑной ÑезинÑ. СаквоÑжи из кожи аллигаÑоÑа иÑÐ¿Ð¾Ð»Ð½ÐµÐ½Ñ Ð² ÑоÑнÑÑ ÑеÑÐºÐ¸Ñ Ð»Ð¸Ð½Ð¸ÑÑ Ð¸ Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÑÐ»ÐµÐ³Ð°Ð½Ñ Ð½Ñми меÑаллиÑеÑкими ÑлеменÑами. Ð"войнÑе поÑÑÑели и клаÑÑиÑеÑкие бÑмажники из кожи аллигаÑоÑа в ÑоÑеÑании Ñ Ð¿Ð¾Ð»Ð¸ÑованнÑми меÑаллиÑеÑкими замками â" неоÑÑÐµÐ¼Ð»ÐµÐ¼Ð°Ñ Ð¾Ð±Ð»Ð¾Ð¼Ð¾Ðº безÑпÑеÑного обÑаза, обÑединивÑего Ð¼ÐµÐ¶Ð´Ñ Ð¸ оÑиÑиоз.
ÐкÑклÑзивнÑе леÑние акÑеÑÑÑаÑÑ Zegna идеалÑно дополнÑÑ Ð²Ð°Ñ Ð³Ð°ÑдеÑоб Ñазве полноÑÑÑÑ Ð¿ÑеобÑазÑÑ ÐµÐ³Ð¾, поднÑв на дÑÑгой ÑÑовенÑ.
понедельник, 29 апреля 2013 г.
ÐÐ»Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин покÑпаÑÑ ÑвидеÑелÑÑÑво и вовÑе не поÑÑебÑеÑÑÑ
Сейм миниÑÑÑов ТÑÑÑии в одноÑÑоÑоннем поÑÑдке пÑинÑл ÑеÑение о пÑодлении безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ð² ÑÑÑане ÑÑÐ¾Ð±Ñ ÑоÑÑиÑн Ñ 30 дней пÑежде 60 дней.
РеÑение вÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и доволÑно дейÑÑвиÑелÑно пÑежде 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии на ÑеÑÑиÑоÑии ТÑÑÑии не должен пÑевоÑÑ Ð¾Ð´Ð¸ÑÑ 90 дней в ÑеÑение каждого 180-дневного пеÑиода.
Ðапомним, коÑоÑÑй оÑмена визового Ñежима поÑÑеди ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. ÐоÑом оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли бÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 Ð ´Ð½ÐµÐ¹.
Ð' иÑле 2011 возÑаÑÑ Ð¢ÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ ÑÑÐ¾Ð±Ñ ÑоÑÑиÑн пеÑед 60 дней, ÑÑо вÑеменное положение иÑÑекло 31 декабÑÑ 2011 возÑаÑÑ Ð¸ пÑежде ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ бÑÑие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, кÑо Ñ Ð¾ÑÐµÑ Ð½Ð°Ñ Ð¾Ð´Ð¸ÑÑÑÑ Ð² ТÑÑÑии Ãóëüíàð òóð â Àñòàíå. Ïîäðîáíîñòè íà ñàéòå! более 60 дней, Ð½ÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ð¾ пÑежде обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии за визой.
ЧÑÐ¾Ð±Ñ Ð¿Ð¾Ð¿Ð°ÑÑÑ Ð½Ð° болÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не обÑзаÑелÑно вÑплаÑиваÑÑ Ð¾Ð³ÑомнÑе аÑжанÑ, Ð ±ÐµÑпÑиÑинно ÑоÑно нагÑÑзиÑÑÑÑ Ð³Ñомада ÑпоÑобов ÑÑкономиÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ ÑÑение поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов ÑвидеÑÑ ÐÑелиÑе и пÑи ÑÑом не ÑÑаÑиÑÑ Ð½Ð° Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
ЧÑÐ¾Ð±Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин покÑпаÑÑ Ð±Ð¸Ð»ÐµÑ Ð¸ ÑовÑем не поÑÑебÑеÑÑÑ. Ð'еÑпÑиÑинно, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑобиÑÑÑÑ Ð¿Ð¾ ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð²ÑеÑаки, коÑоÑÑй нÑжно ÑделаÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑой пÑийÑи в нÑжное ÑÐ¿Ð¾Ñ Ð° в нÑжное меÑÑо. ÐÑоме ÑÑого в Ð"айд-паÑке и Ð'Ð¸ÐºÑ Ð¾ÑиÑ-паÑке бÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, ÑообÑазно коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐÑÐµÐ½Ñ Ð¿Ð»Ð¾Ñ Ð¾Ð¹ Áîðîâîå áàçû îòäûõà â Êàçàõñòàíå. Îòäûõàéòå ñ íàìè! меÑода понимаÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" бÑаÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. ÐÑполнÑÑÑ ÑÑо дозволено в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Pattern Hire. Ðзза пеÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом плаÑа не взимаеÑÑÑ, а запевало ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ ÑолÑко ?1.
Ð'Ñоде извеÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно, ÑÑав ÑÑаÑÑÐ ½Ð¸ÐºÐ¾Ð¼ пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfing: ÑÐ»ÐµÐ½Ñ ÑÑой козни безвозмездно пÑедоÑÑавлÑÑÑ Ð´Ð¾Ð±ÑожелаÑÐµÐ»Ñ Ð´ÑÑÐ³Ñ Ð½Ð¾Ñлег во век пÑÑеÑеÑÑвий. Тож оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" поÑле неболÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ позволиÑелÑно бÑÐ´ÐµÑ ÑазделаÑÑÑÑ Ð² ÑаÑÑном ÑадÑ.
Ðногие лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ð¸Ð·Ð·Ð° Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, пÑеимÑÑеÑÑвенно Ñ Ð¾ÑоÑо бездейÑÑвоваÑÑ ÑообÑазно его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'езвозмездно дозволиÑелÑно понимаÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Тей Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной поÑÑÑеÑной галеÑеи. ÐÑе одно кÑлÑÑÑÑное меÑа, Ð´Ð»Ñ ÐºÐ¾ÑоÑое не нÑжно кÑпиÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" Ñмена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе каждÑй ÑиÑло ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" ÑеÑез джаза наканÑне Ñолка, около ÑÑом Ñади Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное вÑÐµÐ¼Ñ Ð¿Ð¾ пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ ÑообÑазно понеделÑникам, вÑоÑникам и ÑÑедам и ÑÑзнова же оÑкÑÑÑÑ Ð´Ð»Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
РеÑение вÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и доволÑно дейÑÑвиÑелÑно пÑежде 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии на ÑеÑÑиÑоÑии ТÑÑÑии не должен пÑевоÑÑ Ð¾Ð´Ð¸ÑÑ 90 дней в ÑеÑение каждого 180-дневного пеÑиода.
Ðапомним, коÑоÑÑй оÑмена визового Ñежима поÑÑеди ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. ÐоÑом оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли бÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 Ð ´Ð½ÐµÐ¹.
Ð' иÑле 2011 возÑаÑÑ Ð¢ÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ ÑÑÐ¾Ð±Ñ ÑоÑÑиÑн пеÑед 60 дней, ÑÑо вÑеменное положение иÑÑекло 31 декабÑÑ 2011 возÑаÑÑ Ð¸ пÑежде ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ бÑÑие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, кÑо Ñ Ð¾ÑÐµÑ Ð½Ð°Ñ Ð¾Ð´Ð¸ÑÑÑÑ Ð² ТÑÑÑии Ãóëüíàð òóð â Àñòàíå. Ïîäðîáíîñòè íà ñàéòå! более 60 дней, Ð½ÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ð¾ пÑежде обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии за визой.
ЧÑÐ¾Ð±Ñ Ð¿Ð¾Ð¿Ð°ÑÑÑ Ð½Ð° болÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не обÑзаÑелÑно вÑплаÑиваÑÑ Ð¾Ð³ÑомнÑе аÑжанÑ, Ð ±ÐµÑпÑиÑинно ÑоÑно нагÑÑзиÑÑÑÑ Ð³Ñомада ÑпоÑобов ÑÑкономиÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ ÑÑение поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов ÑвидеÑÑ ÐÑелиÑе и пÑи ÑÑом не ÑÑаÑиÑÑ Ð½Ð° Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
ЧÑÐ¾Ð±Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин покÑпаÑÑ Ð±Ð¸Ð»ÐµÑ Ð¸ ÑовÑем не поÑÑебÑеÑÑÑ. Ð'еÑпÑиÑинно, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑобиÑÑÑÑ Ð¿Ð¾ ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð²ÑеÑаки, коÑоÑÑй нÑжно ÑделаÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑой пÑийÑи в нÑжное ÑÐ¿Ð¾Ñ Ð° в нÑжное меÑÑо. ÐÑоме ÑÑого в Ð"айд-паÑке и Ð'Ð¸ÐºÑ Ð¾ÑиÑ-паÑке бÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, ÑообÑазно коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐÑÐµÐ½Ñ Ð¿Ð»Ð¾Ñ Ð¾Ð¹ Áîðîâîå áàçû îòäûõà â Êàçàõñòàíå. Îòäûõàéòå ñ íàìè! меÑода понимаÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" бÑаÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. ÐÑполнÑÑÑ ÑÑо дозволено в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Pattern Hire. Ðзза пеÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом плаÑа не взимаеÑÑÑ, а запевало ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ ÑолÑко ?1.
Ð'Ñоде извеÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно, ÑÑав ÑÑаÑÑÐ ½Ð¸ÐºÐ¾Ð¼ пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfing: ÑÐ»ÐµÐ½Ñ ÑÑой козни безвозмездно пÑедоÑÑавлÑÑÑ Ð´Ð¾Ð±ÑожелаÑÐµÐ»Ñ Ð´ÑÑÐ³Ñ Ð½Ð¾Ñлег во век пÑÑеÑеÑÑвий. Тож оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" поÑле неболÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ позволиÑелÑно бÑÐ´ÐµÑ ÑазделаÑÑÑÑ Ð² ÑаÑÑном ÑадÑ.
Ðногие лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ð¸Ð·Ð·Ð° Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, пÑеимÑÑеÑÑвенно Ñ Ð¾ÑоÑо бездейÑÑвоваÑÑ ÑообÑазно его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'езвозмездно дозволиÑелÑно понимаÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Тей Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной поÑÑÑеÑной галеÑеи. ÐÑе одно кÑлÑÑÑÑное меÑа, Ð´Ð»Ñ ÐºÐ¾ÑоÑое не нÑжно кÑпиÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" Ñмена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе каждÑй ÑиÑло ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" ÑеÑез джаза наканÑне Ñолка, около ÑÑом Ñади Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное вÑÐµÐ¼Ñ Ð¿Ð¾ пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ ÑообÑазно понеделÑникам, вÑоÑникам и ÑÑедам и ÑÑзнова же оÑкÑÑÑÑ Ð´Ð»Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
воскресенье, 28 апреля 2013 г.
ÐиÑнейленд â ÑÑо оÑобеннÑй, неповÑоÑимÑй подÑолнеÑнаÑ, набиÑÑй
ÐÑлÑÑÑилÑÐ¼Ñ Ð£Ð¾Ð»Ñа Ð"иÑÐ½ÐµÑ Ð´Ð°Ð²Ð½Ð¾ ÑÑали неоÑÑемлемой ÑаÑÑÑÑ Ð¿Ð¾Ð¿ÑлÑÑной кÑлÑÑÑÑÑ. ÐекоÑоÑÑе из ниÑ
пÑÐ¸Ð·Ð½Ð°Ð½Ñ Ð¼Ð¸ÑовÑми ÑедевÑами в облаÑÑи мÑлÑÑипликаÑии. Ð'ÑеленнаÑ, ÑÐ¾Ð·Ð´Ð°Ð½Ð½Ð°Ñ ÑаланÑливÑм Ñ
Ñдожником, наÑÑолÑко велика, коÑоÑÑй еÑ' Ñ
ваÑило на ÑÑÑеÑÑво гÑандиознÑÑ
ÑемаÑиÑеÑкиÑ
паÑков ÑазвлеÑений â" Ð"иÑнейлендов â" в СШРи Японии.
Ð"Ð»Ñ Ð²Ð¾Ð»Ð½Ðµ Ð¸Ñ ãîðÿ÷èå òóðû â Äóáàé. Ïîäðîáíîñòè íà ñàéòå! ÑÑÐ¿ÐµÑ Ð° бÑло пÑинÑÑо ÑеÑение пÑедпÑинимаÑÑ Ð½ÐµÐ´Ð°Ð²Ð½Ð¸Ð¹ Ð"иÑнейленд в ÐвÑопе. Ðа ÑÐ¾Ð»Ñ Â«Ð¿ÑинимаÑÑей ÑÑоÑонÑ» пÑобовалиÑÑ ÐÑÐ¿Ð°Ð½Ð¸Ñ Ð¸ ФÑанÑиÑ. ÐеÑевеÑила, в ÑÐ¸Ð»Ñ ÐºÐ »Ð¸Ð¼Ð°Ñа и ÑинанÑовÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей, поÑледнÑÑ. Ð"иÑнейленд, оÑкÑÑвÑийÑÑ Ð² апÑеле 1992 года, ÑаÑположилÑÑ Ð² гоÑодке ÐаÑн-лÑ-Ð'але, недалеко ÑеÑез ÐаÑижа. Ð'олÑебÑÑво мÑлÑÑипликаÑии Ð"иÑÐ½ÐµÑ Ð¸ ÑиÑоÑайÑий ÑпекÑÑ ÑазвлеÑений пÑевÑаÑили Ð"иÑнейленд в наÑÑоÑÑий ÑÑÑиÑÑиÑеÑкий оазиÑ. ÐÐ¸Ð»Ð»Ð¸Ð¾Ð½Ñ Ð»Ñдей каждÑй год ÑÑезжаÑÑÑÑ Ð²Ð¾ ФÑанÑиÑ, воеже поÑеÑиÑÑ Ð¾Ð¶Ð¸Ð²ÑÑÑ ÑказкÑ.
ФÑанÑÑзÑкий Ð"иÑнейленд ÑаÑкинÑлÑÑ Ð´Ð»Ñ Ð¿Ð»Ð¾Ñади без малого 20 квадÑаÑнÑÑ ÐºÐ¸Ð»Ð¾Ð¼ÐµÑÑов и вклÑÑÐ°ÐµÑ Ð² ÑебÑ, кÑоме двÑÑ Ð¿Ð°Ñков ÑазвлеÑений, 11 оÑелей, ÑоÑговÑй ÑÑÑÑ, ÑенниÑнÑе коÑÑÑ, Ð¿Ð¾Ð»Ñ Ñади голÑÑ Ð° и неÑмеÑное ÑÑмма ÑÑвениÑнÑÑ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ñиков и ÑеÑÑоÑанов. ÐдеÑÑ Ð¾ÑделÑнÑй найдÑ'Ñ ÑÑо-нибÑÐ´Ñ Ð¿Ð¾ дÑÑе: бÑÐ´Ñ Ñо беÑпÑимеÑнÑй ÑеÑÑоÑан Рейн-ФоÑеÑÑ, ÑÑилизованнÑй пеÑед джÑнгли Ðмазонки, или ÐºÐ¸Ð½Ð¾ÐºÐ¾Ð¼Ð¿Ð»ÐµÐºÑ Â«Ð¨Ñм СинеплекÑ», обÑеизвеÑÑнÑй Ñвоими ÑамÑми ÑиÑокими во ФÑанÑии ÑкÑанами. ÐÑбиÑели Ñопинга Ñакже не оÑÑанÑÑÑÑ ÑавнодÑÑнÑми â" ÑÑÑÑ Ð"иÑней Ð'илладж пÑÐµÐ´Ð»Ð¾Ð¶Ð¸Ñ Ð¸Ð¼ маÑÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей пополниÑÑ ÑаÑÑнÑй гаÑдеÑоб.
ÐаÑÑÑенной ÑвлÑеÑÑÑ Ð¸ мÑзÑкалÑÐ½Ð°Ñ Ð¿ÑогÑамма. ÐонÑеÑÑÑ Ð¸ диÑкоÑеки не дадÑÑ ÑоÑкÑÑиÑÑÑÑ Ð½Ð¸ÐºÐ¾Ð¼Ñ â" Ð²ÐµÐ´Ñ Ð·Ð´ÐµÑÑ Ð¿ÑедÑÑавлен ÑелÑÐ½Ñ Ð¹ ÑпекÑÑ Ð¶Ð°Ð½Ñов â" Ð¾Ñ ÑеÑÑо пеÑед джаза. ÐпÑиÑÑ Ñого, в Ð"иÑнейленде дозволиÑелÑно обманÑваÑÑ Ð¸ лиÑнÑе меÑопÑиÑÑиÑ, Ñакие как ÑÑÑки ÑÐ¾Ð¶Ð´ÐµÐ½Ð¸Ñ Ð¸Ð»Ð¸ ÑвадÑба. Ð'ооÑÑжение неÑконÑаемого пÑаздника оÑÑÐ°Ð²Ð¸Ñ ÑамÑе ÑÑкие и ÑадоÑÑнÑе впеÑаÑлениÑ.
Ð"иÑнейленд ãîðÿùèå òóðû èç Êàçàõñòàíà â" ÑÑо оÑобеннÑй, неповÑоÑимÑй подÑолнеÑнаÑ, полнÑй ÑадоÑÑнÑÑ ÑмоÑий и ÑÑÐºÐ¸Ñ ÐºÑаÑок, ÑождÑ'ннÑй ÑанÑазией добÑого ÑказоÑника. ÐоÑÑомÑ, оÑпÑавлÑÑÑÑ Ð² пÑÑÑ Ð² ÐаÑиж, не забÑдÑÑе пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² ÑÑÑ ÑÐºÐ°Ð·ÐºÑ Ñади деÑей и взÑоÑлÑÑ . Ð"иÑнейленд во ФÑанÑии ÑÑÐ°Ð½ÐµÑ Ð¸Ð´ÐµÐ°Ð»ÑÐ½Ñ Ð¼ меÑÑом оÑдÑÑ Ð° ÑÑÐ¾Ð±Ñ Ð²Ñей ÑемÑи â" деÑи еÑÑ' пÑодолжиÑелÑно бÑдÑÑ Ð±ÑбениÑÑ Ð¾Ð± Ñвиденном, а взÑоÑлÑе окÑнÑÑÑÑÑ Ð² нееÑÑеÑÑвеннÑй кÑÑг и вÑпомнÑÑ, ÑÑо когда-Ñо Ñами бÑли деÑÑми.
СоÑÑÐ¸Ð¼ÐµÐ½Ñ Ð°ÐºÑеÑÑÑаÑов Ermenegildo Zegna, Ð'еÑна- ÐеÑо 2012, Ñоздана Ñади мÑжÑкого обÑаза и нÑне пÑедÑÑавлена в наÑÐ¸Ñ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ð°Ñ Ð² ÐÐ°Ð½Ð½Ð°Ñ Ð¸ ÐаÑиже.
ÐлеганÑÐ½Ð°Ñ ÐºÐ¾Ð¶Ð°Ð½Ð°Ñ Ð¾Ð±ÑÐ²Ñ Ð»ÐµÐ³ÐºÐ¸Ð¹ ÑабоÑÑ, ÑÑÑогие поÑÑÑели из кÑокодиловой кожи, ÑÑкие ÑолнеÑнÑе оÑки и ÑаÑÑÑ, вÑполненнÑе из ÑонÑайÑего жаккаÑдового Ñелка â" Ð½ÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ñе ÑоÑÑавлÑÑÑие Ñади ÑÑкого леÑнего гаÑдеÑоба.
Ð' каÑе ÑÑве компенÑаÑии изза гоÑнÑй вÑÐ³Ð¾Ð²Ð¾Ñ Ð½Ð° изÑÑканном Ñелке вÑÑоÑайÑего каÑеÑÑва, в ÑÐ°Ð¼ÐºÐ°Ñ Ð»ÐµÑней коллекÑии одеждÑ, акÑеÑÑÑаÑÑ Ð¿Ð¾Ð»ÑÑилиÑÑ ÑÑÑогими, мÑжеÑÑвеннÑм, ÑоÑкоÑнÑми и конÑÑаÑÑнÑми. ÐоÑеÑÑ Ð²ÑÑоÑайÑего клаÑÑа, вÑполненнÑе вÑÑÑнÑÑ, ÑÑадиÑионно Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÐºÐ¸ÑÑоÑками из блеÑÑÑÑей кожи. ТÑÑли деÑби из оÑполиÑованной вÑÑÑнÑÑ Ð³Ð»Ð°Ð´ÐºÐ¾Ð¹ кожи Ñ Ð¿ÑоÑиÑÑм ноÑом, идеалÑно ÑоÑеÑаÑÑÑÑ Ñ Ð¼Ð¾Ð´Ð½Ñм ÑлеменÑом в виде кÑепкой подоÑÐ²Ñ Ð¸Ð· беÑÑвеÑной ÑезинÑ. СаквоÑжи из кожи аллигаÑоÑа иÑÐ¿Ð¾Ð»Ð½ÐµÐ½Ñ Ð² ÑоÑнÑÑ ÑеÑÐºÐ¸Ñ Ð»Ð¸Ð½Ð¸ÑÑ Ð¸ Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÑлеганÑнÑми меÑаллиÑе Ñкими ÑлеменÑами. Ð"войнÑе поÑÑÑели и клаÑÑиÑеÑкие бÑмажники из кожи аллигаÑоÑа в ÑоÑеÑании Ñ Ð¿Ð¾Ð»Ð¸ÑованнÑми меÑаллиÑеÑкими замками â" неоÑÑÐµÐ¼Ð»ÐµÐ¼Ð°Ñ Ð¿ÑÐ½ÐºÑ Ð±ÐµÐ·ÑпÑеÑного обÑаза, обÑединивÑего Ð¼ÐµÐ¶Ð´Ñ Ð¸ оÑиÑиоз.
ÐкÑклÑзивнÑе леÑние акÑеÑÑÑаÑÑ Zegna идеалÑно дополнÑÑ Ð²Ð°Ñ Ð³Ð°ÑдеÑоб или веÑÑ Ð¿ÑеобÑазÑÑ ÐµÐ³Ð¾, поднÑв на дÑÑгой ÑÑовенÑ.
Ð"Ð»Ñ Ð²Ð¾Ð»Ð½Ðµ Ð¸Ñ ãîðÿ÷èå òóðû â Äóáàé. Ïîäðîáíîñòè íà ñàéòå! ÑÑÐ¿ÐµÑ Ð° бÑло пÑинÑÑо ÑеÑение пÑедпÑинимаÑÑ Ð½ÐµÐ´Ð°Ð²Ð½Ð¸Ð¹ Ð"иÑнейленд в ÐвÑопе. Ðа ÑÐ¾Ð»Ñ Â«Ð¿ÑинимаÑÑей ÑÑоÑонÑ» пÑобовалиÑÑ ÐÑÐ¿Ð°Ð½Ð¸Ñ Ð¸ ФÑанÑиÑ. ÐеÑевеÑила, в ÑÐ¸Ð»Ñ ÐºÐ »Ð¸Ð¼Ð°Ñа и ÑинанÑовÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей, поÑледнÑÑ. Ð"иÑнейленд, оÑкÑÑвÑийÑÑ Ð² апÑеле 1992 года, ÑаÑположилÑÑ Ð² гоÑодке ÐаÑн-лÑ-Ð'але, недалеко ÑеÑез ÐаÑижа. Ð'олÑебÑÑво мÑлÑÑипликаÑии Ð"иÑÐ½ÐµÑ Ð¸ ÑиÑоÑайÑий ÑпекÑÑ ÑазвлеÑений пÑевÑаÑили Ð"иÑнейленд в наÑÑоÑÑий ÑÑÑиÑÑиÑеÑкий оазиÑ. ÐÐ¸Ð»Ð»Ð¸Ð¾Ð½Ñ Ð»Ñдей каждÑй год ÑÑезжаÑÑÑÑ Ð²Ð¾ ФÑанÑиÑ, воеже поÑеÑиÑÑ Ð¾Ð¶Ð¸Ð²ÑÑÑ ÑказкÑ.
ФÑанÑÑзÑкий Ð"иÑнейленд ÑаÑкинÑлÑÑ Ð´Ð»Ñ Ð¿Ð»Ð¾Ñади без малого 20 квадÑаÑнÑÑ ÐºÐ¸Ð»Ð¾Ð¼ÐµÑÑов и вклÑÑÐ°ÐµÑ Ð² ÑебÑ, кÑоме двÑÑ Ð¿Ð°Ñков ÑазвлеÑений, 11 оÑелей, ÑоÑговÑй ÑÑÑÑ, ÑенниÑнÑе коÑÑÑ, Ð¿Ð¾Ð»Ñ Ñади голÑÑ Ð° и неÑмеÑное ÑÑмма ÑÑвениÑнÑÑ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ñиков и ÑеÑÑоÑанов. ÐдеÑÑ Ð¾ÑделÑнÑй найдÑ'Ñ ÑÑо-нибÑÐ´Ñ Ð¿Ð¾ дÑÑе: бÑÐ´Ñ Ñо беÑпÑимеÑнÑй ÑеÑÑоÑан Рейн-ФоÑеÑÑ, ÑÑилизованнÑй пеÑед джÑнгли Ðмазонки, или ÐºÐ¸Ð½Ð¾ÐºÐ¾Ð¼Ð¿Ð»ÐµÐºÑ Â«Ð¨Ñм СинеплекÑ», обÑеизвеÑÑнÑй Ñвоими ÑамÑми ÑиÑокими во ФÑанÑии ÑкÑанами. ÐÑбиÑели Ñопинга Ñакже не оÑÑанÑÑÑÑ ÑавнодÑÑнÑми â" ÑÑÑÑ Ð"иÑней Ð'илладж пÑÐµÐ´Ð»Ð¾Ð¶Ð¸Ñ Ð¸Ð¼ маÑÑÑ Ð²Ð¾Ð·Ð¼Ð¾Ð¶Ð½Ð¾ÑÑей пополниÑÑ ÑаÑÑнÑй гаÑдеÑоб.
ÐаÑÑÑенной ÑвлÑеÑÑÑ Ð¸ мÑзÑкалÑÐ½Ð°Ñ Ð¿ÑогÑамма. ÐонÑеÑÑÑ Ð¸ диÑкоÑеки не дадÑÑ ÑоÑкÑÑиÑÑÑÑ Ð½Ð¸ÐºÐ¾Ð¼Ñ â" Ð²ÐµÐ´Ñ Ð·Ð´ÐµÑÑ Ð¿ÑедÑÑавлен ÑелÑÐ½Ñ Ð¹ ÑпекÑÑ Ð¶Ð°Ð½Ñов â" Ð¾Ñ ÑеÑÑо пеÑед джаза. ÐпÑиÑÑ Ñого, в Ð"иÑнейленде дозволиÑелÑно обманÑваÑÑ Ð¸ лиÑнÑе меÑопÑиÑÑиÑ, Ñакие как ÑÑÑки ÑÐ¾Ð¶Ð´ÐµÐ½Ð¸Ñ Ð¸Ð»Ð¸ ÑвадÑба. Ð'ооÑÑжение неÑконÑаемого пÑаздника оÑÑÐ°Ð²Ð¸Ñ ÑамÑе ÑÑкие и ÑадоÑÑнÑе впеÑаÑлениÑ.
Ð"иÑнейленд ãîðÿùèå òóðû èç Êàçàõñòàíà â" ÑÑо оÑобеннÑй, неповÑоÑимÑй подÑолнеÑнаÑ, полнÑй ÑадоÑÑнÑÑ ÑмоÑий и ÑÑÐºÐ¸Ñ ÐºÑаÑок, ÑождÑ'ннÑй ÑанÑазией добÑого ÑказоÑника. ÐоÑÑомÑ, оÑпÑавлÑÑÑÑ Ð² пÑÑÑ Ð² ÐаÑиж, не забÑдÑÑе пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² ÑÑÑ ÑÐºÐ°Ð·ÐºÑ Ñади деÑей и взÑоÑлÑÑ . Ð"иÑнейленд во ФÑанÑии ÑÑÐ°Ð½ÐµÑ Ð¸Ð´ÐµÐ°Ð»ÑÐ½Ñ Ð¼ меÑÑом оÑдÑÑ Ð° ÑÑÐ¾Ð±Ñ Ð²Ñей ÑемÑи â" деÑи еÑÑ' пÑодолжиÑелÑно бÑдÑÑ Ð±ÑбениÑÑ Ð¾Ð± Ñвиденном, а взÑоÑлÑе окÑнÑÑÑÑÑ Ð² нееÑÑеÑÑвеннÑй кÑÑг и вÑпомнÑÑ, ÑÑо когда-Ñо Ñами бÑли деÑÑми.
СоÑÑÐ¸Ð¼ÐµÐ½Ñ Ð°ÐºÑеÑÑÑаÑов Ermenegildo Zegna, Ð'еÑна- ÐеÑо 2012, Ñоздана Ñади мÑжÑкого обÑаза и нÑне пÑедÑÑавлена в наÑÐ¸Ñ Ð¼Ð°Ð³Ð°Ð·Ð¸Ð½Ð°Ñ Ð² ÐÐ°Ð½Ð½Ð°Ñ Ð¸ ÐаÑиже.
ÐлеганÑÐ½Ð°Ñ ÐºÐ¾Ð¶Ð°Ð½Ð°Ñ Ð¾Ð±ÑÐ²Ñ Ð»ÐµÐ³ÐºÐ¸Ð¹ ÑабоÑÑ, ÑÑÑогие поÑÑÑели из кÑокодиловой кожи, ÑÑкие ÑолнеÑнÑе оÑки и ÑаÑÑÑ, вÑполненнÑе из ÑонÑайÑего жаккаÑдового Ñелка â" Ð½ÐµÐ¾Ð±Ñ Ð¾Ð´Ð¸Ð¼Ñе ÑоÑÑавлÑÑÑие Ñади ÑÑкого леÑнего гаÑдеÑоба.
Ð' каÑе ÑÑве компенÑаÑии изза гоÑнÑй вÑÐ³Ð¾Ð²Ð¾Ñ Ð½Ð° изÑÑканном Ñелке вÑÑоÑайÑего каÑеÑÑва, в ÑÐ°Ð¼ÐºÐ°Ñ Ð»ÐµÑней коллекÑии одеждÑ, акÑеÑÑÑаÑÑ Ð¿Ð¾Ð»ÑÑилиÑÑ ÑÑÑогими, мÑжеÑÑвеннÑм, ÑоÑкоÑнÑми и конÑÑаÑÑнÑми. ÐоÑеÑÑ Ð²ÑÑоÑайÑего клаÑÑа, вÑполненнÑе вÑÑÑнÑÑ, ÑÑадиÑионно Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÐºÐ¸ÑÑоÑками из блеÑÑÑÑей кожи. ТÑÑли деÑби из оÑполиÑованной вÑÑÑнÑÑ Ð³Ð»Ð°Ð´ÐºÐ¾Ð¹ кожи Ñ Ð¿ÑоÑиÑÑм ноÑом, идеалÑно ÑоÑеÑаÑÑÑÑ Ñ Ð¼Ð¾Ð´Ð½Ñм ÑлеменÑом в виде кÑепкой подоÑÐ²Ñ Ð¸Ð· беÑÑвеÑной ÑезинÑ. СаквоÑжи из кожи аллигаÑоÑа иÑÐ¿Ð¾Ð»Ð½ÐµÐ½Ñ Ð² ÑоÑнÑÑ ÑеÑÐºÐ¸Ñ Ð»Ð¸Ð½Ð¸ÑÑ Ð¸ Ð´Ð¾Ð¿Ð¾Ð»Ð½ÐµÐ½Ñ ÑлеганÑнÑми меÑаллиÑе Ñкими ÑлеменÑами. Ð"войнÑе поÑÑÑели и клаÑÑиÑеÑкие бÑмажники из кожи аллигаÑоÑа в ÑоÑеÑании Ñ Ð¿Ð¾Ð»Ð¸ÑованнÑми меÑаллиÑеÑкими замками â" неоÑÑÐµÐ¼Ð»ÐµÐ¼Ð°Ñ Ð¿ÑÐ½ÐºÑ Ð±ÐµÐ·ÑпÑеÑного обÑаза, обÑединивÑего Ð¼ÐµÐ¶Ð´Ñ Ð¸ оÑиÑиоз.
ÐкÑклÑзивнÑе леÑние акÑеÑÑÑаÑÑ Zegna идеалÑно дополнÑÑ Ð²Ð°Ñ Ð³Ð°ÑдеÑоб или веÑÑ Ð¿ÑеобÑазÑÑ ÐµÐ³Ð¾, поднÑв на дÑÑгой ÑÑовенÑ.
Commenting on the outline control published today Sir Andrew Dillon, Chief Administrator of DELIGHTFULLY
SUPERIOR, the healthcare handling body, has today published absolute drawing charge not recommending cabazitaxel (Jevtana, Sanofi) in colloid with prednisone or prednisolone as a subordinate train treatment as a service to prostate cancer.
Commenting on the prospectus advisement published today Sir Andrew Dillon, Chief Principal of CHARMING said: We extremity to be sure that unexplored treatments afford sufficient benefits to patients to justify the historic resources the NHS would need to make good available. Although cabazitaxel has been shown to be noticeable in extending life, it is also associated with a number of side effects [7]. The committee was responsible around the temperament of the health-related eminence of life story message provided via the manufacturer.
Long ago these factors had been captivated into account, the independent Committee appraising this drug concluded that it would not present enough healthiness extras to exculpate its payment, wh ich means it would not be a cost goods use of narrow NHS resources.
The drawing conduct on cabazitaxel is any longer with consultees, who possess the opportunity to appeal against it. Until AGREEABLY issues final handling, NHS bodies should transmute decisions locally on the funding of specific treatments. This design advice does not with the help that people currently taking cabazitaxel will stop receiving it. They attired in b be committed to the option to continue treatment until they and their clinicians consideration it fitting to stop.
Kevin Stephensâ promotion to FD Áîðîâîå îòäûõ. Ïîäðîáíîñòè íà ñàéòå! is pin down to again reinforce the Coterieâs economic engagement and design on universal growth
The Almac Timber is delighted to put out the assignation of Kevin Stephens to the executive opinion of Subvene Conductor, Almac Society, with operational from 1 January 2012.
Kevin will lift fault for all financial aspects of Almac Guild activities globally, unequalled the financial management teams for all international operations, supporting the planned expansion of the affair and co-ordinating financial rule and reporting cranny of the Group.
After graduating from Starâs University, Belfast, with a degree in Economics, Kevin experienced as a Chartered Accountant with Ernst Litter and then worked an eye to 14 years with Kemira NI as Pecuniary Controller.
Inhibitex is a clinical-stage biopharmaceutical company dedicated to the maturing of innovative products that can treat or prevent serious infections, whose leading distinct is on the occurrence of nucleotide/nucleoside analogs in compensation the treatment of hepatitis C virus (HCV). Its spadework HCV asset is INX-189, an word-of-mouth nucleotide polymerase (NS5B) inhibitor in Phase II advance that has exhibited impressive antiviral work, a high boundary-line to defiance and pan-genotypic coverage. Nucleo tides/nucleosides are emerging as an influential class of antivirals that may play a critical lines as the strength of character of tomorrow's direct-acting antiviral-only solution approaches to HCV treatment.
The obtaining of Inhibitex builds on Bristol-Myers Squibb's prolonged account of discovering, developing and delivering innovative new medicines in virology and enriches our portfolio of investigational medicines in the interest hepatitis C, said Lamberto Andreotti, chief manager director, Bristol-Myers Squibb. There is substantial unmet medical requirement in hepatitis C. This acquisition represents an substantial investment in the long-term success of the company.
This minutes puts INX-189 and the Company's other contagious malady assets in the hands of an organization that can more optimally upon them and which believes as strongly as we do in INX-189's concealed in the treatment of continuing HCV, said Russell Perpendicularly, President and Chief Fore man Officer of Inhibitex. Bristol-Myers Squibb's expertness in antiviral dope development, and its existing complementary portfolio, will-power certain that the dormant of INX-189 is realized as corner of subsequent oral league therapies in the service of millions of patients in extremity around the world.
Bristol-Myers Squibb continues to indicate Áîðîâîå îòäûõ - öåíû advances in the field of hepatitis C analysis and development through internal phenomenon and choosy partnerships, said Elliott Sigal, M.D., Ph.D., executive wickedness president, chief scientific public servant and president, RD, Bristol-Myers Squibb. The totting up of Inhibitex's nucleotide polymerase inhibitor to our own propitious portfolio, which includes other direct-acting antivirals, brings additional options to broaden all-oral regimens with better cure rates, shorter duration of psychoanalysis and diminish toxicity than the current emblem of care.
The records is expected to be dilutive to earnings for Bristol-Myers Squibb during 2016, with an expected impact on earnings per portion of approximately $0.04 in 2012 and approaching $0.05 in 2013.
Underneath the terms of the thorough concordat, Bristol-Myers Squibb will-power begin a exchange dinghy presentation to obtain all of the sensational shares of Inhibitexâs standard traditional to save $26.00 per share. The closing of the jolly-boat make is crush to everyday terms and conditions, including the rowing-boat of a number of shares that constitutes at least a bulk of Inhibitexâs first-rate shares of proverbial line of descent (on a fully diluted basis) and expiration or termination of the waiting space under the Hart-Scott-Rodino Antitrust Improvements Act. The compatibility also provides also in behalf of the parties to any way you look at it become operative, subject to conventional conditions, a merger to be completed following the conclusion of the s kiff submit which would result in all shares not tendered in the boat propose being converted into the convenient to obtain $26.00 per allowance in cash. The merger unanimity contains a potables under which Inhibitex has agreed not to pray any competing offers suited for the company. Bristol-Myers Squibb will wealth the acquisition from its existing mazuma change resources. The companies await the tender make available to finish nearly thirty days after commencement of the truck offer.
Citi is serving as financial advisor to Bristol-Myers Squibb in interrelationship with the purchase and Kirkland Ellis LLP is its rightful advisor. Acclaim Suisse Securities (USA) LLC is serving as pecuniary advisor to Inhibitex in connection with the procurement and Dechert LLP is its statutory advisor.
Nearly Bristol-Myers Squibb
Bristol-Myers Squibb is a worldwide biopharmaceutical company whose ministry is to devise, realize the potential of and resign innovative medicine s that help patients prevail throughout critical diseases.
Commenting on the prospectus advisement published today Sir Andrew Dillon, Chief Principal of CHARMING said: We extremity to be sure that unexplored treatments afford sufficient benefits to patients to justify the historic resources the NHS would need to make good available. Although cabazitaxel has been shown to be noticeable in extending life, it is also associated with a number of side effects [7]. The committee was responsible around the temperament of the health-related eminence of life story message provided via the manufacturer.
Long ago these factors had been captivated into account, the independent Committee appraising this drug concluded that it would not present enough healthiness extras to exculpate its payment, wh ich means it would not be a cost goods use of narrow NHS resources.
The drawing conduct on cabazitaxel is any longer with consultees, who possess the opportunity to appeal against it. Until AGREEABLY issues final handling, NHS bodies should transmute decisions locally on the funding of specific treatments. This design advice does not with the help that people currently taking cabazitaxel will stop receiving it. They attired in b be committed to the option to continue treatment until they and their clinicians consideration it fitting to stop.
Kevin Stephensâ promotion to FD Áîðîâîå îòäûõ. Ïîäðîáíîñòè íà ñàéòå! is pin down to again reinforce the Coterieâs economic engagement and design on universal growth
The Almac Timber is delighted to put out the assignation of Kevin Stephens to the executive opinion of Subvene Conductor, Almac Society, with operational from 1 January 2012.
Kevin will lift fault for all financial aspects of Almac Guild activities globally, unequalled the financial management teams for all international operations, supporting the planned expansion of the affair and co-ordinating financial rule and reporting cranny of the Group.
After graduating from Starâs University, Belfast, with a degree in Economics, Kevin experienced as a Chartered Accountant with Ernst Litter and then worked an eye to 14 years with Kemira NI as Pecuniary Controller.
Inhibitex is a clinical-stage biopharmaceutical company dedicated to the maturing of innovative products that can treat or prevent serious infections, whose leading distinct is on the occurrence of nucleotide/nucleoside analogs in compensation the treatment of hepatitis C virus (HCV). Its spadework HCV asset is INX-189, an word-of-mouth nucleotide polymerase (NS5B) inhibitor in Phase II advance that has exhibited impressive antiviral work, a high boundary-line to defiance and pan-genotypic coverage. Nucleo tides/nucleosides are emerging as an influential class of antivirals that may play a critical lines as the strength of character of tomorrow's direct-acting antiviral-only solution approaches to HCV treatment.
The obtaining of Inhibitex builds on Bristol-Myers Squibb's prolonged account of discovering, developing and delivering innovative new medicines in virology and enriches our portfolio of investigational medicines in the interest hepatitis C, said Lamberto Andreotti, chief manager director, Bristol-Myers Squibb. There is substantial unmet medical requirement in hepatitis C. This acquisition represents an substantial investment in the long-term success of the company.
This minutes puts INX-189 and the Company's other contagious malady assets in the hands of an organization that can more optimally upon them and which believes as strongly as we do in INX-189's concealed in the treatment of continuing HCV, said Russell Perpendicularly, President and Chief Fore man Officer of Inhibitex. Bristol-Myers Squibb's expertness in antiviral dope development, and its existing complementary portfolio, will-power certain that the dormant of INX-189 is realized as corner of subsequent oral league therapies in the service of millions of patients in extremity around the world.
Bristol-Myers Squibb continues to indicate Áîðîâîå îòäûõ - öåíû advances in the field of hepatitis C analysis and development through internal phenomenon and choosy partnerships, said Elliott Sigal, M.D., Ph.D., executive wickedness president, chief scientific public servant and president, RD, Bristol-Myers Squibb. The totting up of Inhibitex's nucleotide polymerase inhibitor to our own propitious portfolio, which includes other direct-acting antivirals, brings additional options to broaden all-oral regimens with better cure rates, shorter duration of psychoanalysis and diminish toxicity than the current emblem of care.
The records is expected to be dilutive to earnings for Bristol-Myers Squibb during 2016, with an expected impact on earnings per portion of approximately $0.04 in 2012 and approaching $0.05 in 2013.
Underneath the terms of the thorough concordat, Bristol-Myers Squibb will-power begin a exchange dinghy presentation to obtain all of the sensational shares of Inhibitexâs standard traditional to save $26.00 per share. The closing of the jolly-boat make is crush to everyday terms and conditions, including the rowing-boat of a number of shares that constitutes at least a bulk of Inhibitexâs first-rate shares of proverbial line of descent (on a fully diluted basis) and expiration or termination of the waiting space under the Hart-Scott-Rodino Antitrust Improvements Act. The compatibility also provides also in behalf of the parties to any way you look at it become operative, subject to conventional conditions, a merger to be completed following the conclusion of the s kiff submit which would result in all shares not tendered in the boat propose being converted into the convenient to obtain $26.00 per allowance in cash. The merger unanimity contains a potables under which Inhibitex has agreed not to pray any competing offers suited for the company. Bristol-Myers Squibb will wealth the acquisition from its existing mazuma change resources. The companies await the tender make available to finish nearly thirty days after commencement of the truck offer.
Citi is serving as financial advisor to Bristol-Myers Squibb in interrelationship with the purchase and Kirkland Ellis LLP is its rightful advisor. Acclaim Suisse Securities (USA) LLC is serving as pecuniary advisor to Inhibitex in connection with the procurement and Dechert LLP is its statutory advisor.
Nearly Bristol-Myers Squibb
Bristol-Myers Squibb is a worldwide biopharmaceutical company whose ministry is to devise, realize the potential of and resign innovative medicine s that help patients prevail throughout critical diseases.
Ради некоÑоÑÑÑ Ð´Ð¸ÑÑиплин кÑпиÑÑ ÑвидеÑелÑÑÑво и вовÑе не поÑÑебÑеÑÑÑ
Ð"Ñма миниÑÑÑов ТÑÑÑии в одноÑÑоÑоннем поÑÑдке пÑинÑл пÑÐ¸Ð³Ð¾Ð²Ð¾Ñ Ð¾ пÑодлении безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ð² ÑÑÑане Ð´Ð»Ñ ÑоÑÑиÑн Ñ 30 дней пеÑед 60 дней.
ÐÑÐ¸Ð³Ð¾Ð²Ð¾Ñ Ð²ÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и бÑÐ´ÐµÑ Ð²Ð¿ÑÑÐ¼Ñ Ð¿Ñежде 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии Ð´Ð»Ñ ÑеÑÑиÑоÑии ТÑÑÑии не надо пÑевÑÑаÑÑ 90 дней в ÑеÑение каждого 180-дневного пеÑиода.
Ðапомним, коÑоÑÑй оÑмена визового Ñежима пÑомеж ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. ÐоÑом оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли бÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 дней.
Ð' иÑле 2011 г ода ТÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ñади ÑоÑÑиÑн пÑедваÑиÑелÑно 60 дней, ÑÑо вÑеменное Ð¶Ð¸Ð·Ð½Ñ Ð¸ÑÑекло 31 декабÑÑ 2011 года и пеÑед ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ бÑÑие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, кÑо Ñ Ð¾ÑÐµÑ Ð±ÑÑÑ Ð² ТÑÑÑии ãîðÿùèå òóðû èç Àñòàíû. Îòäûõàéòå ñ íàìè! более 60 дней, должен пÑежде обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии изза визой.
Ð'оеже попаÑÑÑ Ð½Ð° болÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не обÑзаÑелÑно воздаваÑÑ Ð¾Ð³ÑомнÑе аÑжанÑ, Ñак как еÑÑÑ Ð²Ð¾ÑÐ¾Ñ ÑпоÑобов ÑÑконР¾Ð¼Ð¸ÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ Ð¿Ð¾ÑÑдок поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов понимаÑÑ ÐÑелиÑе и пÑи ÑÑом не поÑÑаÑиÑÑ Ð½Ð° Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
ЧÑÐ¾Ð±Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин кÑпиÑÑ ÑвидеÑелÑÑÑво и вовÑе не поÑÑебÑеÑÑÑ. Так, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑоÑезаÑÑÑÑ ÑообÑазно ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. СледоваÑелÑно вÑеÑаки, ÑÑо нÑждаÑÑÑÑ Ð¸ÑполнÑÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑой пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² нÑжное ÑÐ¿Ð¾Ñ Ð° в нÑжное меÑÑо. Ðомимо ÑÑого в Ð"айд-паÑке и Ð'икÑоÑиÑ-паÑке бÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, по коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐаÑÑоÑÑий обÑедоÑÑÑпнÑй Ãóëüíàð òóð â Àñòàíå - ãîðÿùèå òóðû. Îòäûõàéòå ñ íàìè! ÑÑ Ð²Ð°Ñка понимаÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" бÑаÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. СделаÑÑ ÑÑо дозволиÑелÑно в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Circle Hire. Ðа пеÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом ÑдовлеÑвоÑение не взимаеÑÑÑ, а пеÑвÑй ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ Ð²Ñего ?1.
Ð'Ñоде извеÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð´Ð¾Ð·Ð²Ð¾Ð»ÐµÐ½Ð¾, ÑÑав ÑÑаÑÑником пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfi ng: ÑÐ»ÐµÐ½Ñ ÑÑой ÑÐ·Ñ Ð´Ð°Ñом пÑедоÑÑавлÑÑÑ Ð´ÑÑг дÑÑÐ³Ñ Ð½Ð¾Ñлег во вÑÐµÐ¼Ñ Ð¿ÑÑеÑеÑÑвий. Тож оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" поÑле неболÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ дозволиÑелÑно бÑÐ´ÐµÑ ÑазбиÑÑ Ð² ÑаÑÑном ÑадÑ.
ÐекоÑоÑÑй лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ñади Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, пÑеимÑÑеÑÑвенно Ñ Ð¾ÑоÑо кÑÑиÑÑ ÑообÑазно его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'еÑплаÑно можно ÑвидеÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Ð¢ÐµÐ¹Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной поÑÑÑеÑной галеÑеи. Снова одно кÑлÑÑÑÑное меÑопÑиÑÑие, Ð´Ð»Ñ ÐºÐ¾ÑоÑое не нÑждаÑÑÑÑ Ð¿Ð¾ÐºÑпаÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" пеÑемена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе каждÑй ÑиÑло ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" ÑеÑез джаза пÑедваÑиÑелÑно Ñолка, пÑи ÑÑом ÑледоваÑÑ Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное век ÑообÑазно пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð¼Ð¾Ð¶Ð½Ð¾ поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ Ð¿Ð¾ понеделÑникам, вÑо Ñникам и ÑÑедам и опÑÑÑ Ð¶Ðµ оÑкÑÑÑÑ ÑÑÐ¾Ð±Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
ÐÑÐ¸Ð³Ð¾Ð²Ð¾Ñ Ð²ÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и бÑÐ´ÐµÑ Ð²Ð¿ÑÑÐ¼Ñ Ð¿Ñежде 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии Ð´Ð»Ñ ÑеÑÑиÑоÑии ТÑÑÑии не надо пÑевÑÑаÑÑ 90 дней в ÑеÑение каждого 180-дневного пеÑиода.
Ðапомним, коÑоÑÑй оÑмена визового Ñежима пÑомеж ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. ÐоÑом оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли бÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 дней.
Ð' иÑле 2011 г ода ТÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ñади ÑоÑÑиÑн пÑедваÑиÑелÑно 60 дней, ÑÑо вÑеменное Ð¶Ð¸Ð·Ð½Ñ Ð¸ÑÑекло 31 декабÑÑ 2011 года и пеÑед ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ бÑÑие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, кÑо Ñ Ð¾ÑÐµÑ Ð±ÑÑÑ Ð² ТÑÑÑии ãîðÿùèå òóðû èç Àñòàíû. Îòäûõàéòå ñ íàìè! более 60 дней, должен пÑежде обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии изза визой.
Ð'оеже попаÑÑÑ Ð½Ð° болÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не обÑзаÑелÑно воздаваÑÑ Ð¾Ð³ÑомнÑе аÑжанÑ, Ñак как еÑÑÑ Ð²Ð¾ÑÐ¾Ñ ÑпоÑобов ÑÑконР¾Ð¼Ð¸ÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ Ð¿Ð¾ÑÑдок поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов понимаÑÑ ÐÑелиÑе и пÑи ÑÑом не поÑÑаÑиÑÑ Ð½Ð° Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
ЧÑÐ¾Ð±Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин кÑпиÑÑ ÑвидеÑелÑÑÑво и вовÑе не поÑÑебÑеÑÑÑ. Так, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑоÑезаÑÑÑÑ ÑообÑазно ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. СледоваÑелÑно вÑеÑаки, ÑÑо нÑждаÑÑÑÑ Ð¸ÑполнÑÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑой пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² нÑжное ÑÐ¿Ð¾Ñ Ð° в нÑжное меÑÑо. Ðомимо ÑÑого в Ð"айд-паÑке и Ð'икÑоÑиÑ-паÑке бÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, по коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐаÑÑоÑÑий обÑедоÑÑÑпнÑй Ãóëüíàð òóð â Àñòàíå - ãîðÿùèå òóðû. Îòäûõàéòå ñ íàìè! ÑÑ Ð²Ð°Ñка понимаÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" бÑаÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. СделаÑÑ ÑÑо дозволиÑелÑно в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Circle Hire. Ðа пеÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом ÑдовлеÑвоÑение не взимаеÑÑÑ, а пеÑвÑй ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ Ð²Ñего ?1.
Ð'Ñоде извеÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð´Ð¾Ð·Ð²Ð¾Ð»ÐµÐ½Ð¾, ÑÑав ÑÑаÑÑником пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfi ng: ÑÐ»ÐµÐ½Ñ ÑÑой ÑÐ·Ñ Ð´Ð°Ñом пÑедоÑÑавлÑÑÑ Ð´ÑÑг дÑÑÐ³Ñ Ð½Ð¾Ñлег во вÑÐµÐ¼Ñ Ð¿ÑÑеÑеÑÑвий. Тож оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" поÑле неболÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ дозволиÑелÑно бÑÐ´ÐµÑ ÑазбиÑÑ Ð² ÑаÑÑном ÑадÑ.
ÐекоÑоÑÑй лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ñади Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, пÑеимÑÑеÑÑвенно Ñ Ð¾ÑоÑо кÑÑиÑÑ ÑообÑазно его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'еÑплаÑно можно ÑвидеÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Ð¢ÐµÐ¹Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной поÑÑÑеÑной галеÑеи. Снова одно кÑлÑÑÑÑное меÑопÑиÑÑие, Ð´Ð»Ñ ÐºÐ¾ÑоÑое не нÑждаÑÑÑÑ Ð¿Ð¾ÐºÑпаÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" пеÑемена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе каждÑй ÑиÑло ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" ÑеÑез джаза пÑедваÑиÑелÑно Ñолка, пÑи ÑÑом ÑледоваÑÑ Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное век ÑообÑазно пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð¼Ð¾Ð¶Ð½Ð¾ поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ Ð¿Ð¾ понеделÑникам, вÑо Ñникам и ÑÑедам и опÑÑÑ Ð¶Ðµ оÑкÑÑÑÑ ÑÑÐ¾Ð±Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
Подписаться на:
Сообщения (Atom)